Lawyers from DLA Piper have played a key role in two high-profile, multimillion pound deals.
The firm has advised Sheffield City Council on the £2 billion Streets Ahead highways maintenance project which will bring improvements to more than 1,200 miles of roads and nearly 2,200 miles of footpaths.
The international law firm, which has offices in the city, provided advice on the development and negotiation of the project documentation, working closely with the council’s project team throughout the course of the procurement, which commenced in 2009.
Amy Oakley, Sheffield City Council’s legal lead for the Streets Ahead project, said: “This is a huge city-wide project.
“The DLA Piper team was an invaluable resource throughout, supporting the Council with timely and expert advice to ensure we were able to reach a successful financial close.
“It’s fantastic news for Sheffield and we are now looking forward to facilitating the delivery of our improvement plans.”
Lloyds Bank acted as lead arranger for the funding for the project and documentation bank.
Meanwhile, a team of lawyers from DLA Piper’s Sheffield office has advised global pharmaceuticals company Pfizer on the sale of the 297-acre former research and development site in Kent where Viagra was developed.
The site once employed 2,400 people and includes research laboratories, offices, a waste water treatment plant and other facilities and has been acquired by a private consortium known as Discovery Park, comprising Palmer Capital, Wynyard and Helios Properties.
DLA Piper acted on behalf of Pfizer on the lease back of 250,000 square foot of space on the site and also recently acted for the pharmaceuticals firm on the disposal of a sports and social club, child care facilities and a nature reserve and the leasing of a high temperature incinerator and solvent handling facility to Augean Treatment.
Sheffield partner Teresa Hitchcock was supported by Vikki McKay, Matthew Shaw, Mike Pocock, Rachel Scales and Elizabeth Wiseman. The team worked with colleagues in London to bring the deal to a successful completion.
Paul Jayson, a partner in DLA Piper’s Real Estate Group and lead partner for the transaction said: “We are extremely pleased to have acted for our long-standing client Pfizer on a significant matter to them and to have played an important role in the history of the facility.”